In the present study, we extended prior work and examined the plasma levels of four targets (TROP2, TSPAN6, NGFR, and BST2) by ELISA of a small sample set of CRC patients and controls and further selected BST2 for detailed analysis. The gene discussed is TSPAN6; the disease is colorectal carcinoma.